Bone Metabolism Discrepancy in Type 2 Diabetes Mellitus Patients With and Without Non-Alcoholic Fatty Liver Disease
- 1 October 2022
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Densitometry
- Vol. 25 (4), 553-558
- https://doi.org/10.1016/j.jocd.2022.07.003
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Use of bone turnover markers in the management of osteoporosisCurrent Opinion in Endocrinology, Diabetes and Obesity, 2018
- Non-alcoholic fatty liver disease – A global public health perspectiveJournal of Hepatology, 2018
- Molecular Modulation of Osteoblasts and Osteoclasts in Type 2 DiabetesJournal of Diabetes Research, 2018
- Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetesDiabetes & Metabolism, 2018
- Increased risk of osteoporosis in patients with nonalcoholic fatty liver diseaseMedicine, 2018
- Precision medicine in the management of type 2 diabetesThe Lancet Diabetes & Endocrinology, 2018
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver DiseasesJournal of Hepatology, 2017
- Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variabilityOsteoporosis International, 2017
- Vitamin D activities and metabolic bone diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 2013
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2010